Tuesday, March 5, 2019

GE: Notably Undervalued After Blockbuster Biopharma Deal - Seeking Alpha

https://ift.tt/eA8V8J

  1. GE: Notably Undervalued After Blockbuster Biopharma Deal  Seeking Alpha
  2. GE Stock Could Almost Double to $20, Says Analyst  Barron's
  3. View full coverage on Google News


from Top stories - Google News https://ift.tt/2tPwS3P

0 komentar

Post a Comment